Catalys Pacific logo

Catalys Pacific

Asia, Tokyo, Japan, Tokyo

Description

Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences

Investor Profile

Catalys Pacific has made 11 investments, with 2 in the past 12 months and 18% as lead.

Stage Focus

  • Series A (45%)
  • Series B (27%)
  • Seed (9%)
  • Private Equity (9%)
  • Series Unknown (9%)

Country Focus

  • United States (73%)
  • Japan (27%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Biopharma
  • Medical
  • Health Care
  • Therapeutics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Catalys Pacific frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 3
DaVita Venture Group
North America, Colorado, United States, Denver
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 4
Richard King Mellon Foundation
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 2
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 4
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 2
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Sahsen Ventures
North America, Washington, United States, Seattle
Co-Investments: 2
Greenspring Associates
North America, Maryland, United States, Owings Mills
Co-Investments: 2

What are some of recent deals done by Catalys Pacific?

Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series BAug 20, 2024
Amount Raised: $105,000,000
Renalys Pharma

Tokyo, Tokyo, Japan

Renalys Pharma is a private, late-stage clinical biopharmaceutical business in Japan focused on the discovery of novel medications.

Series AJul 17, 2024
Amount Raised: $37,956,446
Arialys Therapeutics

La Jolla, California, United States

Arialys Therapeutics is a pre-clinical stage company that develops auto-antibody focusing on neuroscience.

Health CareMedicalTherapeutics
SeedSep 12, 2023
Amount Raised: $58,000,000
Pathalys Pharma

Raleigh, North Carolina, United States

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

BiopharmaBiotechnology
Series AJan 18, 2023
Amount Raised: $150,000,000
Mineralys Therapeutics

Radnor, Pennsylvania, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

BiopharmaBiotechnologyMedicalPharmaceutical
Series BJun 8, 2022
Amount Raised: $118,000,000
Aculys Pharma

Fujisawa, Kanagawa, Japan

Aculys Pharma is a pharmaceutical company that aims to develop innovative and superior medical methods and deliver them to patients.

Pharmaceutical
Series BMar 28, 2022
Amount Raised: $22,652,622
Aculys Pharma

Fujisawa, Kanagawa, Japan

Aculys Pharma is a pharmaceutical company that aims to develop innovative and superior medical methods and deliver them to patients.

Pharmaceutical
Series AOct 28, 2021
Amount Raised: $59,850,198
HilleVax

Boston, Massachusetts, United States

HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownSep 8, 2021
Amount Raised: $135,000,000
Mineralys Therapeutics

Radnor, Pennsylvania, United States

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

BiopharmaBiotechnologyMedicalPharmaceutical
Series AApr 6, 2021
Amount Raised: $40,000,000
Exalys Therapeutics

San Diego, California, United States

Exalys Therapeutics is focused on the development of first-in-class therapies for the treatment of inflammatory disorders.

BiotechnologyLife ScienceTherapeutics
Series AJul 16, 2020
Amount Raised: $15,000,000